참고문헌
- Voedisch AJ, Frederick CE, Nicosia AF, Stovall TG. Early pregnancy loss and ectopic pregnancy. In: Berek JS, Novak E, editors. Berek & Novak's gynecology. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2012. p. 873-924.
- Menon S, Colins J, Barnhart KT. Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: a systematic review. Fertil Steril 2007;87:481-4. https://doi.org/10.1016/j.fertnstert.2006.10.007
- American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 94: medical management of ectopic pregnancy. Obstet Gynecol 2008;111:1479-85. https://doi.org/10.1097/AOG.0b013e31817d201e
- Lipscomb GH, McCord ML, Stovall TG, Huff G, Portera SG, Ling FW. Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies. N Engl J Med 1999;341:1974-8. https://doi.org/10.1056/NEJM199912233412604
- Nguyen Q, Kapitz M, Downes K, Silva C. Are early human chorionic gonadotropin levels after methotrexate therapy a predictor of response in ectopic pregnancy? Am J Obstet Gynecol 2010;202:630.e1-5. https://doi.org/10.1016/j.ajog.2010.03.022
- Gabbur N, Sherer DM, Hellmann M, Abdelmalek E, Phillip P, Abulafia O. Do serum beta-human chorionic gonadotropin levels on day 4 following methotrexate treatment of patients with ectopic pregnancy predict successful single-dose therapy? Am J Perinatol2006;23:193-6.
- Skubisz MM, Tong S. The evolution of methotrexate as a treatment for ectopic pregnancy and gestational trophoblastic neoplasia: a review. ISRN Obstet Gynecol 2012;2012:637094.
- Lipscomb GH, Puckett KJ, Bran D, Ling FW. Management of separation pain after single-dose methotrexate therapy for ectopic pregnancy. Obstet Gynecol 1999;93:590-3. https://doi.org/10.1016/S0029-7844(98)00523-7
- Barnhart KT, Gosman G, Ashby R, Sammel M. The medical management of ectopic pregnancy: a meta-analysis comparing "single dose" and "multidose" regimens. Obstet Gynecol 2003;101:778-84. https://doi.org/10.1016/S0029-7844(02)03158-7
- da Costa Soares R, Elito J Jr, Camano L. Increment in beta-hCG in the 48-h period prior to treatment: a new variable predictive of therapeutic success in the treatment of ectopic pregnancy with methotrexate. Arch Gynecol Obstet 2008;278:319-24. https://doi.org/10.1007/s00404-008-0589-4
- Dudley PS, Heard MJ, Sangi-Haghpeykar H, Carson SA, Buster JE. Characterizing ectopic pregnancies that rupture despite treatment with methotrexate. Fertil Steril 2004;82:1374-8. https://doi.org/10.1016/j.fertnstert.2004.03.066
- Takacs P, Rodriguez L. High folic acid levels and failure of singledose methotrexate treatment in ectopic pregnancy. Int J Gynaecol Obstet 2005;89:301-2. https://doi.org/10.1016/j.ijgo.2004.11.036
피인용 문헌
- Pretreatment serum human chorionic gonadotropin cutoff value for medical treatment success with single-dose and multi-dose regimen of methotrexate in tubal ectopic pregnancy vol.60, pp.1, 2014, https://doi.org/10.5468/ogs.2017.60.1.79